Literature DB >> 31165345

Direct oral anticoagulants in lipoprotein apheresis: handle with care.

Francesco Sbrana1, Beatrice Dal Pino2, Angela Papa3, Federico Bigazzi2, Luca Panchetti4, Tiziana Sampietro2.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31165345     DOI: 10.1007/s11739-019-02118-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  7 in total

1.  Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.

Authors:  Carsten P Bramlage; Victor W Armstrong; Antonia Zapf; Peter Bramlage; Gerhard A Mueller; Michael J Koziolek
Journal:  Ther Apher Dial       Date:  2010-04       Impact factor: 1.762

Review 2.  The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures.

Authors:  Armando Tripodi; Francesco Marongiu; Marco Moia; Gualtiero Palareti; Vittorio Pengo; Daniela Poli; Domenico Prisco; Sophie Testa; Maria Zanazzi
Journal:  Intern Emerg Med       Date:  2018-04-26       Impact factor: 3.397

3.  Italian intersociety consensus on DOAC use in internal medicine.

Authors:  Domenico Prisco; Walter Ageno; Cecilia Becattini; Armando D'Angelo; Giovanni Davì; Raimondo De Cristofaro; Francesco Dentali; Giovanni Di Minno; Anna Falanga; Gualberto Gussoni; Luca Masotti; Gualtiero Palareti; Pasquale Pignatelli; Roberto M Santi; Francesca Santilli; Mauro Silingardi; Antonella Tufano; Francesco Violi
Journal:  Intern Emerg Med       Date:  2017-02-13       Impact factor: 3.397

4.  A case of pulseless electrical activity secondary to pulmonary embolism: A medical emergency occurring in an LDL apheresis center.

Authors:  Francesco Sbrana; Beatrice Dal Pino; Federico Bigazzi; Michele Coceani; Roberta Luciani; Mascia Pianelli; Luca Panchetti; Christina Petersen; Simonetta Monti; Tiziana Sampietro
Journal:  Transfus Apher Sci       Date:  2015-03-14       Impact factor: 1.764

Review 5.  The laboratory and the direct oral anticoagulants.

Authors:  Armando Tripodi
Journal:  Blood       Date:  2013-04-05       Impact factor: 22.113

Review 6.  The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review.

Authors:  Sara M Shunkwiler; Huy P Pham; Geoffrey Wool; Tina S Ipe; Deanna C Fang; Elizabeth Biller; Angela Treml; John Weiss; Beverly W Baron; Mary Berg
Journal:  J Clin Apher       Date:  2017-10-26       Impact factor: 2.821

7.  Oral bioavailability of dabigatran etexilate (Pradaxa(®) ) after co-medication with verapamil in healthy subjects.

Authors:  Sebastian Härtter; Regina Sennewald; Gerhard Nehmiz; Paul Reilly
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.